Deep and Machine Learning for Acute Lymphoblastic Leukemia Diagnosis: A Comprehensive Review

Abstract

The medical condition known as acute lymphoblastic leukemia (ALL) is characterized by an excess of immature lymphocyte production, and it can affect people across all age ranges. Detecting it at an early stage is extremely important to increase the chances of successful treatment. Conventional diagnostic techniques for ALL, such as bone marrow and blood tests, can be expensive and time-consuming. They may be less useful in places with scarce resources. The primary objective of this research is to investigate automated techniques that can be employed to detect ALL at an early stage. This analysis covers both machine learning models (ML), such as support vector machine (SVM) & random forest (RF), as well as deep learning algorithms (DL), including convolution neural network (CNN), AlexNet, ResNet50, ShuffleNet, MobileNet, RNN. The effectiveness of these models in detecting ALL is evident through their ability to enhance accuracy and minimize human errors, which is essential for early diagnosis and successful treatment. In addition, the study also highlights several challenges and limitations in this field, including the scarcity of data available for ALL types, and the significant computational resources required to train and operate deep learning models.